HealthTree Round Tables focus on educating patients and caregivers to understand the complexities of myeloma advances in patient-friendly terms.
HealthTree Round Tables are live (and live-streamed) meetings connecting myeloma patients with experts. Every HealthTree Round Table is unique because the content is tailored to the strengths, experiences, and interests of each faculty member. Each program consists of two sessions focusing on specific topics of interest to the myeloma community.
HealthTree Round Tables include extensive time for attendees to ask questions for the faculty in a format that also allows faculty members to interact and comment on each other’s observations.
Myeloma specialists are excited that audience questions are always complex and informed. This motivates faculty members to learn how to translate more difficult and abstract concepts into language that is patient-friendly.
• "Very good speakers who made it easy for all levels of patients caregivers to follow the discussions.”
• "One of the best meetings and the quality of presenters was inspiring.”
• "As a scientist, this meeting tops many I have attended.”
• "Looking forward to seeing where the Round Tables will be next year.”
Dr. Landgren explains the guiding ideas of the growing myeloma agenda at Sylvester and Dr. Kazandjian explains the treatment strategies in the clinic.
This session features three of the top minds in myeloma today taking deep looks into fundamental issues patients must consider to understand their options.
“I’ve just been diagnosed with myeloma. Now what?” That question leads to serious decisions about treatment strategies that need to be made.
Learn essential information every newly diagnosed patient should know.
Dr. Patel, Dr. Lee, and NP Rebecca Lu explain the considerations they keep in mind when treating relapsed/refractory disease at MD Anderson.
Drs. Orlowski and Qazilbash discuss how precursor conditions and transplants are assessed at MD Anderson as well as what the future may bring.
Last February we conducted a Myeloma Round Table webcast to explain what disparities are and why they matter to the entire patient community.
In this Myeloma Round Table from January 22, 2022, myeloma specialists share their latest research presented at ASH 2021.
Disease progression in relapsed/refractory myeloma